Reporting the clinical importance of randomized controlled trials.

David Moher; Douglas G. Altman; Kenneth F. Schulz

Abstract

1 min read

Karen Chan and colleagues address how well reports of randomized controlled trials discuss the issue of clinical importance.[1][1] We agree with these authors and others[2][2],[3][3] that clinical importance needs to be discussed in the report of any randomized controlled trial. Chan and

Related publications

Article1994

A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group

Erik Andrew, Aslam H. Anis, Mildred K. Cho, Mike Clarke, David T. Felson, Peter C Gøtzsche, Richard E. Greene, Alejandro R. Jadad, Wayne B. Jonas, Terry P. Klassen, Paul Knipschild, Andreas Laupacis, Curtis L. Meinert, David Moher, Graham Nichol, Andy Oxman, Marie-France Penman, Stuart Pocock, Joan Reisch, David L. Sackett, Kenneth F. Schulz, Judy Snider, Peter Tugwell, Jon E. Tyson, France Varin, Wikke Walop, Sharon Walsh, George A. Wells

Article2009

Reporting the clinical importance of randomized controlled trials.

Abstract

Discussion(0)

Related publications

A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group

Randomized trials published in some Chinese journals: how many are randomized?

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials.

We should abandon randomized controlled trials in the intensive care unit